Clinton Group’s Elevance Health ELV Stock Holding History

Clinton Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,880	Closed	-$1.51M	–	394
2018 Q1	$1.51M	Sell	6,880 -28,358	-80%	-$6.66M	0.16%	174
2017 Q4	$7.93M	Sell	35,238 -1,249	-3%	-$266K	0.7%	34
2017 Q3	$6.93M	Buy	36,487 +33,679	+1,199%	+$6.41M	0.76%	31
2017 Q2	$528K	Sell	2,808 -10,021	-78%	-$1.8M	0.05%	398
2017 Q1	$2.12M	Buy	+12,829	New	+$2.04M	0.12%	243
2016 Q3	–	Sell	-82,659	Closed	-$10.9M	–	943
2016 Q2	$10.9M	Buy	82,659 +54,611	+195%	+$7.47M	0.48%	41
2016 Q1	$3.9M	Buy	+28,048	New	+$3.75M	0.23%	123
2015 Q4	–	Sell	-22,956	Closed	-$3.21M	–	778
2015 Q3	$3.21M	Buy	+22,956	New	+$3.45M	0.3%	97
2015 Q1	–	Sell	-6,177	Closed	-$776K	–	516
2014 Q4	$776K	Buy	+6,177	New	+$763K	0.24%	125
2014 Q2	–	Sell	-5,183	Closed	-$516K	–	346
2014 Q1	$516K	Buy	+5,183	New	+$469K	0.19%	168

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Clinton Group's ELV Position: Q2 2018 in Review

Clinton Group sold out of Elevance Health (ELV) in Q2 2018, closing a stake of 6,880 shares — an estimated $1.51M sold.

Clinton Group first reported a position in ELV in Q1 2014 and held it in 10 quarters. The position peaked at $10.9M in Q2 2016. 935 funds tracked by Wall St. Rank hold ELV as of Q2 2018.

Clinton Group reported no remaining Elevance Health position as of Q2 2018 after selling out during the quarter.
Clinton Group sold 6,880 Elevance Health shares in Q2 2018, an estimated $1.51M.
Clinton Group first reported a position in Elevance Health in Q1 2014 and held it in 10 quarters.
Clinton Group's Elevance Health position peaked at $10.9M in Q2 2016.
935 funds tracked by Wall St. Rank held Elevance Health as of Q2 2018.

Based on Clinton Group's 13F filing for Q2 2018, filed 6 Jul 2018.